Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001634626-15-000008
Filing Date
2015-10-07
Accepted
2015-10-07 15:29:38
Documents
1
Period of Report
2015-10-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1425
  Complete submission text file 0001634626-15-000008.txt   2787
Mailing Address
Business Address
GOLISANO B THOMAS (Reporting) CIK: 0000903201 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55181 | Film No.: 151148865

Mailing Address 632 BROADWAY SUITE 201 NEW YORK NY 10012
Business Address 632 BROADWAY SUITE 201 NEW YORK NY 10012 (212) 651-8500
TWINLAB CONSOLIDATED HOLDINGS, INC. (Issuer) CIK: 0001590695 (see all company filings)

EIN.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products